FGFR1 and neoplasm: Moreover, FGFR1 inhibition can reduce proliferation and induce cell death in a variety of in vitro and in vivo tumor models harboring FGFR aberrations, and a growing number of research groups have selected FGFR1 as target for anticancer drug development [29, 40, 41].